By Josh Boak

President Joe Biden is committing to reduce the cancer death rate by 50% — a new goal for the “moonshot” initiative against the disease that was announced in 2016 when he was vice president.

Biden has set a 25-year timeline for achieving that goal, part of his broader effort to end cancer as we know it, according to senior administration officials who previewed Wednesday's announcement on the condition of anonymity.

The issue is deeply personal for Biden: He lost his elder son, Beau, to brain cancer in 2015.

The pain experienced by the president is shared by many Americans. The American Cancer Society estimates that there will be 1,918,030 new cancer cases and 609,360 cancer deaths this year. What Biden is aiming to do is essentially save more than 300,000 lives annually from the disease, something the administration believes is possible because the age-adjusted death rate has already fallen by roughly 25% over the past two decades. The cancer death rate is currently 146 per 100,000 people, down from nearly 200 in 2000.

The American Cancer Society said in a statement that it applauded Biden for “putting national focus on this critical issue” and that “it will be standing shoulder to shoulder” with the administration.

Dr. Barron Lerner, a professor of medicine and population health at New York University Langone Health, said that “hyperbolic goals" can be needed to attract public attention but achieving the 50% reduction is “extremely unlikely.”

“Similar past efforts like the ‘War on Cancer’ have made gains, but they have been more modest,” said Lerner, the author “The Breast Cancer Wars.” “Cancer is many diseases and requires very complicated research. Translating these advances to the clinical setting is never easy either.”

Biden was scheduled to give remarks Wednesday from the East Room of the White House, along with his wife, Jill, and Vice President Kamala Harris. Also scheduled to attend the speech: members of Congress and the administration and about 100 members of the cancer community including patients, survivors, caregivers, families, advocacy groups and research organizations.

As part of the effort, Biden will assemble a “cancer Cabinet” that includes 18 federal departments, agencies and offices, including leaders from the Departments of Health and Human Services, Veterans Affairs, Defense, Energy and Agriculture.

There were no plans to announce new funding commitments on Wednesday, though the administration will outline why it believes it can curb cancer through efforts such as increased screening and removing inequities in treatment. The coronavirus pandemic has consumed health care resources and caused people to miss more than 9.5 million cancer screenings.

The White House also will host a summit on the cancer initiative and continue a roundtable discussion series on the subject. The goal is to improve the quality of treatment and people’s lives, something with deep economic resonance as well. The National Cancer Institute reported in October that the economic burden of treatment was more than $21 billion in 2019, including $16.22 billion in patient out-of-pocket costs.

President Barack Obama announced the cancer program during his final full year in office and secured $1.8 billion over seven years to fund research. Obama designated Biden, then his vice president, as “mission control," a recognition of Biden's grief as a parent and desire to do something about it. Biden wrote in his memoir “Promise Me, Dad” that he chose not to run for president in 2016 primarily because of Beau's death.

When Biden announced he wasn't seeking the Democratic nomination in 2016, he said he regretted not being president because "I would have wanted to have been the president who ended cancer, because it’s possible.”

The effort fell somewhat out of the public focus when Donald Trump became president, though Trump, a Republican, proposed $500 million over 10 years for pediatric cancer research in his 2019 State of the Union address.

Biden continued the work as a private citizen by establishing the Biden Cancer Initiative to help organize resources to improve cancer care. When Biden did seek the presidency in 2020, he had tears in his eyes as he said in an interview on MSNBC's “Morning Joe" that “Beau should be running for president, not me.”

Share:
More In Politics
Stocks Close Monday at Session Lows
Stocks began the week closing at session lows on a day when bond yields rose and President Biden decided to stick with Jerome Powell as Fed Chair. Bryan Lee, Chief Investment Officer at Blue Zone Wealth Advisors, joins Cheddar News' Closing Bell, where he breaks down the day's activity and discusses what the Fed now needs to do going forward.
Markets, Treasuries Tick Up Amid Jerome Powell's Re-Nomination to Fed Chair Position
President Joe Biden announced Monday he is re-nominating Federal Reserve Chairman Jerome Powell after weeks of speculation that he would choose Democrat and Fed Governor Lael Brainard to fill the role. Biden could be looking for continuity as the U.S. continues to grapple with COVID-19 and high inflation, and investors could be on the same page: markets and treasuries ticked up after the White House made the announcement. MarketWatch Senior Reporter Greg Robb joins Cheddar News' Closing Bell to discuss Powell's re-nomination, what we can expect from the Fed's December meeting, whether it will speed up its taper timeline, and more.
Biden Choice to Keep Jerome Powell at Fed Was 'Path of Least Resistance'
President Joe Biden named Jerome Powell, initially appointed by President Trump, to keep his seat as the chair of the Federal Reserve on Monday amid the ongoing challenges of the pandemic, inflation, and unemployment. David Beckworth, a former international economist for the Treasury Department and a senior fellow with the Mercatus Center, joined Cheddar to discuss what he sees as the practicality of Biden's decision. "What Powell brings to the table is he's built up political capital with Republicans and Democrats," he said. "It's easy for him to get the job done. I think in one way he was the path of least resistance for the president."
Elizabeth Holmes to Resume Theranos Testimony
In a surprise turn of events, Elizabeth Holmes took the stand in her own defense on Friday and is expected to continue her testimony later today. Holmes, who founded a blood testing start-up Theranos back in 2003, faces 11 counts of wire fraud as well as conspiracy to commit wire fraud. Aron Solomon, Chief Legal Analyst, Esquire Digital joined Cheddar's Opening Bell to discuss.
House Passes Build Back Better Plan, Goes to Senate
The House narrowly passed President Biden's $1.7 trillion Build Back Better bill, the largest expansion of the social safety net in decades. The final vote was 220 to 213, with only one Democrat joining all Republicans in opposing the bill. It now heads to the Senate, where it faces an uncertain fate. Jennifer Haberkorn, congressional reporter for the Los Angeles Times, joins Cheddar News' Closing Bell, where she breaks down the current version of the bill, where it goes next, and what it could mean for the country if it eventually reaches the president's desk.
Load More